American Society for Microbiology, Journal of Clinical Microbiology, 3(59), 2021
DOI: 10.1128/jcm.02511-20
Full text: Download
As the coronavirus disease 2019 (COVID-19) pandemic second wave is emerging, it is of the upmost importance to screen the population immunity in order to keep track of infected individuals. Consequently, immunoassays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high specificity and positive predictive values are needed to obtain an accurate epidemiological picture.